Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) terminate the authorization of Sanofi to develop, produce and commercialize a new rotavirus vaccine
Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) it was announced that Wantai Canghai, a wholly-owned subsidiary, recently received the notice on terminating the license agreement for new rotavirus vaccine sent by Sanofi. According to the agreement, Wantai Canghai has received the advance authorization license fee of US $10 million paid by Sanofi on August 31, 2020 and fulfilled relevant obligations. The termination of this transaction will not affect the right to receive this amount, Will not have an impact on the company’s earnings.
Essence Information Technology Co.Ltd(688555) shareholders plan to reduce their holdings of no more than 2% of the company’s shares
Essence Information Technology Co.Ltd(688555) according to the announcement, Xinchen investment plan, a shareholder with a shareholding of 6.02%, will reduce its shares by means of centralized competitive bidding within 6 months after 15 trading days from the date of announcement, and the proportion of reduced shares in the total share capital of the company shall not exceed 2%.
Shanghai Topcare Medical Services Co.Ltd(600532) : Shanghai lankuang increased its holding of 1.01% of the company’s shares
According to the announcement of Shanghai Topcare Medical Services Co.Ltd(600532) , Shanghai lankuang increased 5211874 shares of the company through centralized bidding and block trading from December 27, 2021 to December 28, 2021, accounting for 1.01% of the total share capital of the company. After this equity change, the proportion of shares held by Shanghai lankuang increased from 5.00% to 6.01%.
China Shipbuilding Industry Group Power Co.Ltd(600482) plans to jointly invest with China shipbuilding industry group and China Cssc Holdings Limited(600150) to form a joint venture
China Shipbuilding Industry Group Power Co.Ltd(600482) announced that in order to further standardize the horizontal competition of diesel engine business under China Cssc Holdings Limited(600150) group, China Shipbuilding Industry Group Power Co.Ltd(600482) plans to jointly invest and form a joint venture with China shipbuilding industry group and China Cssc Holdings Limited(600150) . The underlying assets used for capital contribution are the equity of China Shipbuilding Power (Group) Co., Ltd., China Cssc Holdings Limited(600150) heavy industry group Diesel Engine Co., Ltd., Shaanxi Diesel Engine Heavy Industry Co., Ltd. and Henan Diesel Engine Heavy Industry Co., Ltd. held by all parties to the transaction. After preliminary negotiation by all parties to the transaction, China Shipbuilding Industry Group Power Co.Ltd(600482) will hold the controlling right of the joint venture after the completion of this transaction. This transaction is expected to constitute a major asset restructuring of the company. After the completion of this transaction, neither the controlling shareholder nor the actual controller of the company will change.
Jiangsu Aidea Pharmaceutical Co.Ltd(688488) plans to jointly develop anti HIV long-acting therapeutic drugs with Pharmablock Sciences (Nanjing) Inc(300725)
According to the announcement of Jiangsu Aidea Pharmaceutical Co.Ltd(688488) , the company and its wholly-owned subsidiary Nanjing Aidi Pharmaceutical Technology Co., Ltd. signed the project cooperation and development framework contract with Pharmablock Sciences (Nanjing) Inc(300725) for the joint development of anti HIV long-acting therapeutic drugs. Both parties jointly determined the targets and indications of anti HIV long-acting therapeutic drugs, and cooperated to determine at least one clinical candidate compound. The down payment of the contract is 2 million yuan (including tax), The cumulative total amount of milestone payment of the contract is 119 million yuan (including tax).
The actual controller of Qianjiang Water Resources Development Co; Ltd(600283) will be changed to the state owned assets supervision and Administration Commission of the State Council, which will resume trading on the 29th
According to the announcement of Qianjiang Water Resources Development Co; Ltd(600283) , on December 9, 2021, China Power Construction Group Co., Ltd. (hereinafter referred to as “Power Construction Group”) signed an agreement with Jiangyin steel pipe. Jiangyin steel pipe transferred its 6% equity of Qianjiang Water Resources Development Co; Ltd(600283) controlling shareholder China water to power construction group, and entrusted the voting right corresponding to its 4% equity of China water to power construction group. On December 23, 2021, Power Construction Group signed the property right transaction contract of Beijing property right exchange with Tuoshi Nuojin. Tuoshi Nuojin transferred its 7.0833% equity of China water to power construction group, and promised to entrust all shareholders’ rights other than shareholders’ income right to power construction group to exercise its 2.9167% equity of China water. After the completion of this transaction, the equity of Qianjiang Water Resources Development Co; Ltd(600283) indirectly owned by PowerChina group through China water will exceed 30% of the issued shares of Qianjiang Water Resources Development Co; Ltd(600283) , and the actual controller of the company will be changed from the comprehensive business bureau of the Ministry of water resources to the state owned assets supervision and Administration Commission of the State Council. The trading of the company’s shares will resume from December 29, 2021.
Cssc Science & Technology Co.Ltd(600072) the controlling shareholder planned major events and suspended trading from 29
According to the announcement of Cssc Science & Technology Co.Ltd(600072) , the indirect controlling shareholder China Cssc Holdings Limited(600150) group is currently planning major matters related to the company, which is expected to involve issuing shares to purchase 100% equity of China Cssc Holdings Limited(600150) heavy industry group haizhuang Wind Power Co., Ltd., China Cssc Holdings Limited(600150) Group Wind Power Development Co., Ltd., 88.58% equity of CSIC Haiwei (Xinjiang) new energy Co., Ltd Luoyang Shuangrui wind power blade Co., Ltd. has 44.64% minority equity and China Shipbuilding Heavy Industry (Wuhan) lingjiu Electric Co., Ltd. has 10% minority equity, and plans to raise supporting funds. This transaction constitutes a connected transaction and is expected to constitute a major asset restructuring, which will not lead to the change of the actual controller of the company. The trading of the company’s shares will be suspended from December 29, 2021, and it is expected that the suspension will not exceed 10 trading days.
Tibet Tourism Co.Ltd(600749) termination of acquisition of 100% equity of Beihai Xinyi cruise ship
Tibet Tourism Co.Ltd(600749) it was announced that previously, the listed company planned to issue shares to ENN holding Investment Co., Ltd. and pay cash to buy 100% equity of Beihai Xinyi cruise ship Co., Ltd. Taking into account the capital market environment and the actual situation of the listed company and other factors, after careful research and friendly negotiation, both parties to the transaction unanimously decided to terminate the transaction.
Camel Group Co.Ltd(601311) will sell the energy storage system to the Three Gorges energy management engineering company
Camel Group Co.Ltd(601311) announcement: on December 28, 2021, camel Group Wuhan New Energy Technology Co., Ltd., a wholly-owned subsidiary of the company, and Three Gorges Energy Management Engineering Co., Ltd., a wholly-owned subsidiary of Three Gorges electric energy, signed the sales and service contract of 15MW / 30mwh energy storage system of camel group Xiangyang Battery Co., Ltd. and the sales and service contract of 10MW / 20mwh energy storage system of camel group Huazhong Battery Co., Ltd, Three Gorges Energy Management Engineering Co., Ltd. purchased 15MW / 30mwh energy storage system and 10MW / 20mwh energy storage system from camel New Energy Technology Co., Ltd.
Gezhouba, a subsidiary of China Energy Engineering Corporation Limited(601868) , plans to transfer 75% equity of Gezhouba financial leasing company for 236 million yuan
China Energy Engineering Corporation Limited(601868) it is announced that Gezhouba, the holding subsidiary of the company, plans to transfer 75% of its equity of China Gezhouba Group Financial Leasing Co., Ltd. to China Energy Construction Group Financial Leasing Co., Ltd. at a transfer price of 236223880.24 yuan.
Yunnan Jianzhijia Health-Chain Co.Ltd(605266) shareholders plan to reduce their total holdings of no more than 3.55% of the company’s shares
Yunnan Jianzhijia Health-Chain Co.Ltd(605266) announcement: the shareholder chengdeye partnership plans to reduce its holdings by not more than 2% of the total shares of the company through call auction and block trading within 6 months after 3 trading days from the date of disclosure of the announcement of the reduction plan; Suzhou Heyi, a shareholder, intends to reduce its holdings by no more than 1.5527% of the total shares of the company through call auction and block trading within 6 months after 3 trading days from the date of disclosure of the announcement of the reduction plan.
Wuhan National Pharmaceutical Technology Co.Ltd(600421) termination of the purchase of 100% equity of core super biology
Wuhan National Pharmaceutical Technology Co.Ltd(600421) announced that the company originally planned to purchase 100% equity of Shanghai Xinchao Biotechnology Co., Ltd. Due to the large number of counterparties involved in the matter and the great differences in the needs of all parties, especially the agreement on the commitment and compensation of the counterparties’ unemployment performance, the company decided to terminate the issue of shares to purchase assets after full discussion with relevant parties. The trading of the company’s shares will resume from the opening of the market on December 29, 2021.
Zhewen Interactive Group Co.Ltd(600986) it is proposed to raise no more than 800 million yuan from indirect controlling shareholders
Zhewen Interactive Group Co.Ltd(600986) it is announced that the company plans to issue non-public shares at an issue price of 4.85 yuan / share. The issuing object is Bowen investment, a wholly-owned subsidiary of Zhejiang cultural investment, the indirect controlling shareholder of the company. The total amount of funds raised does not exceed 80 million yuan. After deducting the issuance expenses, it is planned to be used for AI intelligent marketing system project, live broadcast and short video intelligent marketing ecological platform project, repayment of bank loans and supplement working capital.
Shanghai Putailai New Energy Technology Co.Ltd(603659) the subsidiary plans to build 20000 t / a PVDF and 45000 T / a R142b projects with 1.4 billion yuan
Shanghai Putailai New Energy Technology Co.Ltd(603659) announced that the company’s holding subsidiary Ruyuan Guangdonghectechnologyholdingco.Ltd(600673) fluororesin Co., Ltd. (hereinafter referred to as ” Guangdonghectechnologyholdingco.Ltd(600673) fluororesin”) has reached a preliminary investment intention with the government of Ruyuan Yao Autonomous County, Shaoguan City, Guangdong Province. The company plans to further expand the capacity construction plan on the basis of the original plan, and plans to build 20000 t / a PVDF and 45000 T / a R142b projects through Guangdonghectechnologyholdingco.Ltd(600673) fluororesin, The total investment of the project is about 1.4 billion yuan. After the capacity expansion, it will form a complete supporting with the existing 5000t PVDF capacity of Guangdonghectechnologyholdingco.Ltd(600673) fluororesin, and finally form a 25000t / a PVDF capacity and a supporting 45000 T / a R142b raw material capacity.
Beijing Kawin Technology Share-Holding Co.Ltd(688687) : Peiji interferon α- 2. The first subject of phase III clinical trial of injection was successfully enrolled
Beijing Kawin Technology Share-Holding Co.Ltd(688687) announcement: innovative biological products developed by the company α- The first subject of phase III clinical trial of 2 injection in the treatment of low replication chronic HBV infection was successfully enrolled on December 28, 2021. Peiji interferon α- 2 the hepatitis B indications for hepatitis B have been completed in phase I and II clinical trials. The results of II phase clinical trial show that the interferon is integrated into the culture. α- The efficacy and safety of injection are equivalent to those of imported drugs. This study, guided by the clinical needs of patients who are not satisfied, will break through the staging and treatment concept of hepatitis B, and provide clinical evidence-based evidence for more potential people who can be cured clinically.
Advanced Micro-Fabrication Equipment Inc.China(688012) proposed capital increase of 100 million yuan, ideal wanlihui
Advanced Micro-Fabrication Equipment Inc.China(688012) announcement: in order to improve the business layout, the company plans to invest 100 million yuan in Shanghai ideal wanlihui Film Equipment Co., Ltd. (hereinafter referred to as “ideal wanlihui”) and subscribe for an additional registered capital of 4.24028 million yuan. The shareholding ratio of the company has increased from 3.6929% to 4.7735%. Ideal wanlihui is committed to realizing domestic substitution, cost reduction and efficiency increase of equipment in the field of Cecep Solar Energy Co.Ltd(000591) battery heterojunction. The developed mass-produced VHF-PECVD equipment helps customers obtain heterojunction battery conversion efficiency of 26.30%. Ideal wanlihui has Shanghai R & D center and Taixing production base, with an annual production capacity of more than 15gw.
Tianjin 712 Communication & Broadcasting Co.Ltd(603712) the controlling shareholder intends to reduce the company’s shares by no more than 3%
Tianjin 712 Communication & Broadcasting Co.Ltd(603712) announced that Zhibo technology, the controlling shareholder, plans to reduce the number of shares of the company by block trading and centralized bidding, with a reduction ratio of no more than 3% of the total share capital of the company.
Hunan Haili Chemical Industry Co.Ltd(600731) plans to acquire 100% equity of lithium battery company and layout the new energy field
Hunan Haili Chemical Industry Co.Ltd(600731) announced that the company plans to acquire 100% equity of Hunan Haili Chemical Industry Co.Ltd(600731) lithium battery technology Co., Ltd. (hereinafter referred to as “lithium battery company”) held by Haili group for 97.7737 million yuan. Lithium battery company is a high-tech enterprise specializing in the research, production and sales of lithium battery cathode materials. At present, its main products include power lithium manganate, high-capacity lithium manganate, ternary materials and other products. The products are mainly used in energy storage equipment, power vehicles and high-end electronic products. The company has an annual production capacity of 5000 tons of lithium battery cathode materials (including 4000 tons of lithium manganate), which is the largest R & D and production integration base of lithium manganate in Hunan Province. This equity acquisition is an important measure for the company to layout the new energy field.
Shanghai Lingang Holdings Co.Ltd(600848) it is proposed to establish Shanghai Lingang Holdings Co.Ltd(600848) hydrogen energy industry development Co., Ltd. with the actual controller
According to the announcement of Shanghai Lingang Holdings Co.Ltd(600848) , the company plans to jointly invest with Shanghai Lingang Holdings Co.Ltd(600848) economic development (Group) Co., Ltd. (hereinafter referred to as “Lingang group”) to establish Shanghai Lingang Holdings Co.Ltd(600848) hydrogen energy industry development Co., Ltd. the registered capital of Lingang hydrogen energy company is 1 million yuan, of which the company plans to invest 500 million yuan, accounting for 50% of the shares of Lingang hydrogen energy company; Lingang group plans to invest 500 million yuan, accounting for 50% of the shares of Lingang hydrogen energy company.
The company said that Lingang hydrogen energy company focuses on the in-depth integration of hydrogen energy industry chain resources. Relying on the rapid development of hydrogen energy industry opportunities in Lingang New Area and Lingang group’s participation in the development and operation of rich hydrogen energy application scenario resources in the park, Lingang hydrogen energy company expands the commercial operation of hydrogen energy in transportation, construction, energy and other fields, forming a new energy industry agglomeration effect with hydrogen energy as the theme; At the same time, the company will vigorously cultivate key enterprises in the core link of the hydrogen energy industry chain, and help the port new area to build into a pilot area, comprehensive demonstration area and industrial leading area for hydrogen energy development in Shanghai and even the whole country.
Shanghai Shibei Hi-Tech Co.Ltd(600604) sign two major real estate sales contracts
Shanghai Shibei Hi-Tech Co.Ltd(600604) it was announced that Shibei development, a wholly-owned subsidiary of the company, signed the Shanghai real estate sales contract with Shanghai Jing’an District Center for Disease Control and Prevention (hereinafter referred to as “Jing’an disease control”). Jing’an disease control transferred the real estate located at No. 221, JIANGCHANG Third Road, Jing’an District, Shanghai, which is held by Shibei development. The building area of the house is 6547.21 square meters, and the total transfer price of the above real estate is 248793980.00 yuan. The total net profit expected from the smooth performance of this contract accounts for more than 50% of the audited net profit attributable to the parent company in 2020, which is expected to have a positive impact on the company’s operating revenue and net profit.
The company announced on the same day that Xinyun investment, a wholly-owned subsidiary of the company, signed the Shanghai real estate sales contract with Shanghai Information Investment Co., Ltd. (hereinafter referred to as “Shanghai Information Investment”). The real estate located at No. 25 and No. 26, Lane 1401, JIANGCHANG Road, Jing’an District, Shanghai, transferred by Xinyun investment, with a construction area of 5633.03 square meters, and the total transfer price of the above real estate is 270385440.00 yuan. The total net profit expected from the smooth performance of this contract accounts for more than 50% of the audited net profit attributable to the parent company in 2020, which is expected to have a positive impact on the company’s operating revenue and net profit.
Shanghai Construction Group Co.Ltd(600170) won the bid for more than 5 billion yuan engineering construction project
According to the announcement of Shanghai Construction Group Co.Ltd(600170) , the company has received the letter of acceptance for the construction of phase III expansion project of Bailonggang sewage treatment plant, and the winning price of the project is 5007217300 yuan. The planned construction period is 1432 calendar days.
Lawton Development Co.Ltd(600209) terminate the strategic cooperation framework agreement signed with guohou assets
Lawton Development Co.Ltd(600209) announcement: on December 28, 2021, through friendly negotiation, the company and guohou Asset Management Co., Ltd. jointly signed the termination agreement of the strategic cooperation framework agreement between Lawton Development Co.Ltd(600209) and guohou Asset Management Co., Ltd., and unanimously agreed to terminate the original strategic cooperation framework agreement.
The Sichuan Road & Bridge Co.Ltd(600039) subsidiary signed a general construction contract of about 12 billion yuan
Sichuan Road & Bridge Co.Ltd(600039) it was announced that the wholly-owned subsidiary road and bridge group and Sichuan Zhenguang Expressway Co., Ltd. signed the general contract for the construction of Tongjiang Guang’an contract section (zcbc1) of Zhenba (Sichuan Shaanxi boundary) Guang’an expressway project, which covers the civil engineering, pavement, traffic safety, greening, housing construction, construction and construction of K110 + 500 ~ k219 + 000 in bid section zcbc1 Mechanical and electrical works and corresponding repair works within the defect liability period. The total contract amount is about 12 billion yuan.
Zhejiang Qianjiang Biochemical Co.Ltd(600796) : the first phase of Guangyao thermal power natural gas distributed energy project has been put into use
Zhejiang Qianjiang Biochemical Co.Ltd(600796) announced that after the early project construction, the first phase of Guangyao thermal power natural gas distributed energy project has met the external heating conditions. After several days of trial operation, it has been put into use, mainly supplying heat to enterprises in Haining Economic Development Zone. The original 265 sets of coal-fired boiler units and equipment of Guangyao thermal power and its wholly-owned subsidiary Haining Dongshan Thermal Power Co., Ltd. have been stopped at the same time, It shall be scrapped.
Shanghai Holystar Information Technology Co.Ltd(688330) shareholders plan to reduce their holdings of no more than 2% of the company’s shares
Shanghai Holystar Information Technology Co.Ltd(688330) it is announced that Pinhua investment, a shareholder holding 6.02%, plans to reduce the total number of shares of the company by means of centralized bidding and block trading, accounting for no more than 2000000 shares, accounting for no more than 2% of the total share capital of the company.
(Shanghai Securities News · China Securities Network)
